(Q37860564)

24 August 2017

title

Respiratory manifestations in mucopolysaccharidoses (English)

1 reference

24 August 2017

Respiratory Manifestations in Mucopolysaccharidoses (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

29 November 2024

William Wooten

1 reference

24 August 2017

Joseph Muenzer

series ordinal

1 reference

24 August 2017

Marianne S. Muhlebach

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21458742

29 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21458742

29 November 2024

publication date

26 November 2010

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:S1526054210000990?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

https://api.elsevier.com/content/article/PII:S1526054210000990?httpAccept=text/plain

29 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Paediatric Respiratory Reviews

29 November 2024

published in

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

133-138

1 reference

Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Management of mucopolysaccharidosis type III.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Otorhinolaryngological manifestations of the mucopolysaccharidoses.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Role of the pediatric otolaryngologist in diagnosis and management of children with mucopolysaccharidoses

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Identification of glycosaminoglycans in human airway secretions.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

ABR and temporal bone pathology in Hurler's disease

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Pathological and biochemical study in the adenoid of mucopolysaccharidosis II.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Airway changes in children with mucopolysaccharidoses

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Diagnosis and management of respiratory involvement in Hunter syndrome

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Airway management in mucopolysaccharide storage disorders

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Narrow trachea in mucopolysaccharidoses

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

[Mucopolysaccharidosis 6-A (Maroteaux-Lamy disease): comparison of clinical and pathologico-anatomic findings in a 27-year-old patient]

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Upper airway obstruction in Hunter syndrome

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Management of tracheal lesions in Hurler syndrome

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Tracheobronchial stent insertions in the management of major airway obstruction in a patient with Hunter syndrome (type-II mucopolysaccharidosis)

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Skeletal dysplasias: evaluation with impulse oscillometry and thoracoabdominal motion analysis

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Respiratory complications of mucopolysaccharide storage disorders.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Airway obstruction and sleep apnea in Hurler and Hunter syndromes

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Hurler's syndrome with cor pulmonale secondary to obstructive sleep apnoea treated by continuous positive airway pressure

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Severe type Hunter's syndrome. Polysomnographic and neuropathological study

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Impairment of the melatonin rhythm in children with Sanfilippo syndrome

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Mucopolysaccharidoses and the eye.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Multidisciplinary management of Hunter syndrome.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Mucopolysaccharidosis I: management and treatment guidelines

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Anaesthetic considerations in the mucopolysaccharidoses

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

The mucopolysaccharidoses and anaesthesia: a report of clinical experience

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Anaesthesia for children with mucopolysaccharidoses.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Children with mucopolysaccharidosis: perioperative care, morbidity, mortality, and new findings

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Acute airway obstruction in Hunter syndrome

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoses

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I.

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.10.005

29 November 2024

Identifiers

1 reference

24 August 2017

1 reference